Who owns MOLECULIN BIOTECH INC COM?
- CUSIP Number: 60855d309
Tip: Access positions for across all investors
Analyze quarterly positions in Moleculin Biotech with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Moleculin Biotech stock
Who bought or sold MOLECULIN BIOTECH INC COM this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
Armistice Capital | 149k | $878k | 100% | Mar 2024 |
|
Vanguard Group | 75k | $445k | 100% | Mar 2024 |
|
Geode Capital Management | 17k | $98k | 100% | Mar 2024 |
|
BlackRock | 13k | $74k | 100% | Mar 2024 |
|
Atticus Wealth Management | 3.3k | $20k | 100% | Mar 2024 |
|
Newbridge Financial Services Group | 685.00 | $4.0k | 100% | Mar 2024 |
|
Tower Research Capital | 621.00 | $3.7k | 100% | Mar 2024 |
|
Morgan Stanley | 423.00 | $2.5k | 100% | Mar 2024 |
|
Fwl Investment Management | 278.00 | $1.6k | 100% | Mar 2024 |
|
Sandy Spring Bank | 89.00 | $525.998900 | 100% | Mar 2024 |
|
Advisor Group Holdings | 65.00 | $383.812000 | 100% | Mar 2024 |
|
Wells Fargo & Company | 19.00 | $111.765600 | 100% | Mar 2024 |
|
North Star Investment Management | 16.00 | $95.000000 | 100% | Mar 2024 |
|
Nbc Securities | 14.00 | $1.0k | 100% | Mar 2024 |
|
Royal Bank of Canada | 10.00 | $0 | 100% | Mar 2024 |
|
Jpmorgan Chase & Co | 7.00 | $40.999700 | 100% | Mar 2024 |
|
Bank of America Corporation | 7.00 | $40.999700 | 100% | Mar 2024 |
|
Goss Wealth Management | 1.00 | $6.000000 | 100% | Mar 2024 |
|